The federal government’s sudden rationing of monoclonal antibody treatments, which keep Americans who get COVID-19 out of hospitals, is hitting Alabama hard, with some sites already running out of or projected to run out of supply soon. The antibodies are highly successful at stemming the effects of COVID-19 when given to patients soon after they contract the disease, which is caused by the CCP (Chinese Communist Party) virus. But a huge jump in demand in recent weeks has left what some officials have described as a national shortage, triggering the federal government to intervene and start doling out what’s left. Stringfellow and Regional Medical Center in Anniston didn’t have any of the antibodies left on Wednesday, according to Dr. Almena Free, vice president of medical affairs and chief medical officer. Other facilities in Jefferson and Huntsville counties are struggling to source enough of the treatment, Dr. David Thrasher, a pulmonary critical care …